Using a 2-step uIRI, during the 49-day observation period, plasma BUN and creatinine concentrations were significantly lower, and the degree of renal fibrosis was significantly milder, in mice treated with the anti-CD300a mAb than in mice treated with the control antibody (Supplemental Figure 6, B and C). Here, CD300A is linked to renal fibrosis.